SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 33 | -21.4% | 0.00% | – |
| Q1 2022 | $1,000 | -99.7% | 42 | -99.5% | 0.00% | -100.0% |
| Q3 2021 | $354,000 | +378.4% | 7,995 | +515.0% | 0.02% | +533.3% |
| Q2 2021 | $74,000 | +1133.3% | 1,300 | +1429.4% | 0.00% | – |
| Q1 2021 | $6,000 | -14.3% | 85 | +1.2% | 0.00% | -100.0% |
| Q4 2020 | $7,000 | +40.0% | 84 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | +66.7% | 84 | +6.3% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 79 | -17.7% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 96 | +33.3% | 0.00% | – |
| Q4 2019 | $5,000 | -64.3% | 72 | -28.7% | 0.00% | -100.0% |
| Q3 2019 | $14,000 | -26.3% | 101 | -1.0% | 0.00% | 0.0% |
| Q2 2019 | $19,000 | +216.7% | 102 | +183.3% | 0.00% | – |
| Q1 2019 | $6,000 | -100.0% | 36 | -98.1% | 0.00% | -100.0% |
| Q2 2018 | $296,781,000 | +470981.0% | 1,896 | +387.4% | 0.03% | +333.3% |
| Q1 2018 | $63,000 | +117.2% | 389 | +117.3% | 0.01% | +200.0% |
| Q4 2017 | $29,000 | +2800.0% | 179 | +1018.8% | 0.00% | – |
| Q3 2017 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |